U.S. Markets open in 8 hrs
  • S&P Futures

    3,358.25
    +12.25 (+0.37%)
     
  • Dow Futures

    27,575.00
    +93.00 (+0.34%)
     
  • Nasdaq Futures

    11,428.75
    +34.00 (+0.30%)
     
  • Russell 2000 Futures

    1,511.00
    +4.50 (+0.30%)
     
  • Crude Oil

    40.32
    -0.28 (-0.69%)
     
  • Gold

    1,884.00
    +1.70 (+0.09%)
     
  • Silver

    23.63
    +0.03 (+0.11%)
     
  • EUR/USD

    1.1673
    +0.0004 (+0.0350%)
     
  • 10-Yr Bond

    0.6630
    0.0000 (0.00%)
     
  • Vix

    26.19
    -0.19 (-0.72%)
     
  • GBP/USD

    1.2847
    +0.0006 (+0.0450%)
     
  • BTC-USD

    10,700.82
    -1.68 (-0.02%)
     
  • CMC Crypto 200

    220.15
    -3.77 (-1.69%)
     
  • FTSE 100

    5,927.93
    +85.26 (+1.46%)
     
  • Nikkei 225

    23,620.87
    +109.25 (+0.46%)
     

Beigene (BGNE) CEO John Oyler Sold $14.2 million of Shares

GuruFocus.com

- By insider

CEO of Beigene (30-Year Financial, Insider Trades) John Oyler (insider trades) sold 61,042 shares of BGNE on 09/02/2020 at an average price of $233.21 a share. The total sale was $14.2 million.


BeiGene Ltd is a biopharmaceutical company engaged in the discovery and development of molecularly targeted and immuno-oncology drugs for the treatment of cancer. Its product includes BGB-3111, BGB-A317 and BGB-290 and one immuno-oncology agent. BeiGene Ltd has a market cap of $21.58 billion; its shares were traded at around $234.94 with and P/S ratio of 70.68. GuruFocus has detected 5 severe warning signs with BeiGene Ltd. .

CEO Recent Trades:

  • CEO John Oyler sold 61,042 shares of BGNE stock on 09/02/2020 at the average price of $233.21. The price of the stock has increased by 0.74% since.

  • CEO John Oyler sold 92,177 shares of BGNE stock on 08/21/2020 at the average price of $237.06. The price of the stock has decreased by 0.89% since.

  • CEO John Oyler sold 42,968 shares of BGNE stock on 08/14/2020 at the average price of $212.71. The price of the stock has increased by 10.45% since.

  • CEO John Oyler sold 17,254 shares of BGNE stock on 08/05/2020 at the average price of $223.27. The price of the stock has increased by 5.23% since.

  • CEO John Oyler sold 40,559 shares of BGNE stock on 08/04/2020 at the average price of $221.27. The price of the stock has increased by 6.18% since.

Directors and Officers Recent Trades:

  • CMO, Hematology Jane Huang sold 3,000 shares of BGNE stock on 08/28/2020 at the average price of $242.21. The price of the stock has decreased by 3% since.

  • Director Timothy Yung-cheng Chen sold 7,000 shares of BGNE stock on 08/12/2020 at the average price of $212.92. The price of the stock has increased by 10.34% since.

  • Chair, Scientific Advisory Brd Xiaodong Wang sold 4,000 shares of BGNE stock on 08/10/2020 at the average price of $211.06. The price of the stock has increased by 11.31% since.

For the complete insider trading history of BGNE, click here

.This article first appeared on GuruFocus.